Atlas Trials

Study to Determine the Pharmacokinetics of GSK961081 and Fluticasone Furoate When Administered Alone or in Combination

Clinical trial NCT02064504 · COMPLETED

Trial details

NCT number
NCT02064504
Sponsor
GlaxoSmithKline
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Pulmonary Disease, Chronic Obstructive
Start date
2014-02-19
Primary completion
2014-05-20
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.